m7G modification affects the cellular composition of the immune microenvironment in ovarian cancer, and two key m7G modification-regulated genes, DCP2 and NUDT16, promotes the proliferation and metastases of ovarian cancer cells, and its high expression is associated with poor prognosis. Here, DCP2 is linked to ovarian carcinoma.